The present invention relates to the use of guanidinoacetic acid and a method of treating caudophagia in pigs.

The present invention relates to a composition for growing the population of microorganisms in a gut of monogastric animals, and methods for growing the same. The present invention also relates to a method for enhancing an average daily gain of monogastric animals.

The present invention relates to a composition for growing the population of microorganisms in a gut of monogastric animals, and methods for growing the same. The present invention also relates to a method for enhancing an average daily gain of monogastric animals.

A composition contains quercetagetin and 6-hydroxykaempferol, and, optionally further includes patuletin. The composition has an excellent antioxidant effect, and can be used as an active additive in food, drugs, health care products, cosmetics, and feed. In addition, the composition can prompt animal growth, reduce ratio of feed to gain, and improve meat quality in the feed.

The present disclosure relates to a composition for prevention or treatment of cancer, the composition containing, as an active ingredient, a strain belonging to the genus Leuconostoc, isolated from kimchi, or a culture thereof. The genus Leuconostoc strain or the culture thereof according to the present disclosure exhibits excellent anticancer activity, and thus can be advantageously used as a composition for use in treatment, prevention, alleviation, or the like, of human or animal cancer.

Use of a seaweed blend to modify gastrointestinal (GI) microbiota of an animal host. Modifying the GI microbiota may comprise modifying a community of bacteria, wherein the community of bacteria comprises Firmicutes and Bacteriodetes and the seaweed blend modifies the ratio of Firmicutes to Bacteriodetes, such as increasing the ratio of Firmicutes to Bacteriodetes. Further, the seaweed blend modifies specific families of commensal bacteria families including Ruminococceae and Lachnospiraceae within the Phyla Firmicutes. The seaweed blend may comprise (i) 65-80 wt % Ulva; (ii) 3-8 wt % Gracilaria; and (iii) 15-25 wt % Sargassum and/or Ascophyllum.

Use of a seaweed blend to modify gastrointestinal (GI) microbiota of an animal host. Modifying the GI microbiota may comprise modifying a community of bacteria, wherein the community of bacteria comprises Firmicutes and Bacteriodetes and the seaweed blend modifies the ratio of Firmicutes to Bacteriodetes, such as increasing the ratio of Firmicutes to Bacteriodetes. Further, the seaweed blend modifies specific families of commensal bacteria families including Ruminococceae and Lachnospiraceae within the Phyla Firmicutes. The seaweed blend may comprise (i) 65-80 wt % Ulva; (ii) 3-8 wt % Gracilaria; and (iii) 15-25 wt % Sargassum and/or Ascophyllum.

The present invention is related to the inclusion of dehydrated and encapsulated functional additives formulations in food matrices.

For the encapsulation of the additives, molten hydrophobic mixtures of fatty acids and longchain saponified fatty acids were used under simple encapsulation techniques that require minimum residence times and early solidification.

These specific mixtures of coating materials and the manufacturing process confer physical and chemical resistance to the formulated additives, which allows their use as functional ingredients in industrial processes, such as the production of balanced foods, concentrated foods, dry or wet foods, for humans or animals; where extrusion, baking or pelletizing processes are used, without the additives losing their viability and activity.

Milk replacers include milk and non-milk proteins, and at least a portion of the non-milk protein is provided by textured soy protein. The textured soy protein is ground and extruded such that it is substantially free of anti-nutritional factors that are detrimental to young animal health or development. The milk replacers with textured soy proteins are fed to young animals, who demonstrate equal or improved performance compared to young animals fed milk replacers with the same amount of total protein and same amount of soy protein, but the soy protein is from other than textured soy protein.

An isolated Bacillus altitudinis strain as deposited with the National Collection of Industrial and Marine Bacteria under the Accession No. NCIMB 43558 on 27/01/2020.